Virus-like particles (VLPs) are nanostructures that possess diverse applications in
therapeutics, immunization, and diagnostics. With the recent advancements in biomedical …

The greatest obstacle to using drugs to treat brain tumors is the blood‐brain barrier (BBB),
making it difficult for conventional drug molecules to enter the brain. Therefore, how to safely …

Virus-like nanoparticles (VLPs) are natural polymer-based nanomaterials that mimic viral
structures through the hierarchical assembly of viral coat proteins, while lacking viral …

Protein nanocages have emerged as an important engineering platform for biotechnological
and biomedical applications. Among naturally occurring protein cages, encapsulin …

RNA-based therapeutics have emerged as promising approaches to modulate gene
expression and generate therapeutic proteins or antigens capable of inducing immune …

Viral diseases represent a major public health concerns and ever-present risks for
developing into future pandemics. Antiviral antibody therapeutics, either alone or in …

Radiation‐induced lung injury (RILI) is a potentially fatal and dose-limiting complication of
thoracic cancer radiotherapy. However, effective therapeutic agents for this condition are …

Nanoparticles (NPs) have been widely used as target delivery vehicles for therapeutic
goods; however, compared with inorganic and organic nanomaterials, protein …

The rapid evolution of new SARS-CoV-2 variants poses a continuing threat to human health.
Vaccination has become the primary therapeutic intervention. The goal of the current work …

The rapid advancement of nanotechnology in recent years has opened new avenues of
investigation for biomedical sciences. Viral nanoparticles (VNPs) are formulated from plant …